Does Conscious Connected Breathwork Reduce Symptoms of Anxiety?
NCT ID: NCT06374810
Last Updated: 2024-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2023-09-21
2023-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions aims to answer:
1. Does conscious connected breathwork reduce symptoms of anxiety?
2. Does an increased frequency of self-practice lead to even greater reductions of anxiety symptoms.
there is a comparison group: Researchers will compare whether people doing the breathwork to see if \[insert effects\].
Participants will participate in 1, 90 minute breath workshop per week for 6 weeks. These sessions will be held on Zoom by 2 facilitators. Participants will also be given a 10 minute recording of a guided conscious connected breathwork session that they will be encouraged to complete daily.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Coherent Breathing Breathwork on Health
NCT05676658
Psychophysiological Effects of Controlled Respiration and Mindfulness
NCT05304000
Baduanjin Training for Depression and Anxiety Patients
NCT05589337
Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety
NCT07259005
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
NCT01693874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
Participants in the breathwork groups were also given a 10 minute guided conscious connected breathwork recording. They were advised to do this daily to support the integration of their process. This was not mandatory. At the end of the study participants were asked how often they used the guided self-practice. The frequency of use of the self-practice was used a covariate.
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathwork Group
This group participated in 6 weeks of 90-minute Conscious Connected Breathwork groups conducted via Zoom. Participants attended 1 workshop per week
Conscious Connected Breathwork
Participants were taught the Conscious Connected Breathwork Technique. 2 facilitators were monitoring and coaching the participants to ensure adherence to the technique
Waitlist control group
This group were told the 1st cohort of the study was full and they would be permitted to join cohort 2 in 6 weeks time. At the end of this waitlist period participants were invited to join the second cohort so long as they still met the inclusion criteria.
Placebo waitlist
Participants were told the study was full and that they were placed on a waiting list until the 1st cohort had completed the breathwork program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conscious Connected Breathwork
Participants were taught the Conscious Connected Breathwork Technique. 2 facilitators were monitoring and coaching the participants to ensure adherence to the technique
Placebo waitlist
Participants were told the study was full and that they were placed on a waiting list until the 1st cohort had completed the breathwork program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Anyone who has recently (within 1 year) started anti-depressant medication or psychotherapy
* Anyone with a history of panic disorder, psychosis, angina, pregnant, seizure disorder, glaucoma
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Richard Blake
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Blake
PhD Candidate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CIIS
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCB1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.